\
&
Contact us
\
&
Contact us
This was 7 months ago
LocationOn-line
ProgrammesThe Commission organises a webinar explaning the new policy regarding 2-factor authentication of the near future. No need to register beforehand to follow this webinar. All details can be found here. You can also go directly to the Commission You tube channel: EU Science & Innovation - YouTube (tab live).
The European Commission has launched a EUSurvey - Survey so you can better understand two-factor authentication (2FA) for your EU Login account. They claim the survey will take you not more than 2 minutes. They want to learn what potential obstacles you see in using two-factor authentication. For your information: from Mid 2025 the authentication method through SMS will be phased out.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
